US Approval For SPP 100 Combined With Diuretic To Treat Hypertension
January 22nd, 2008 by samospsipsi
Speedel Holding Ltd (SWX: SPPN) announced that it is delighted by the FDA approval of a second product containing SPP100 (aliskiren) in the USA for the treatment of hypertension. The approval was announced by Novartis who is responsible for commercialisation of this first in class direct renin inhibitor.
More: continued here







